LDS/Medical Tests/Chromosome Analysis, Amniotic Fluid

Chromosome Analysis, Amniotic Fluid

Amniotic fluid chromosome analysis is a test in which amniotic fluid is removed (amniocentesis) and examined to determine if the proper number of chromosomes are present and if each chromosome contains all of the elements (genetic material, bands) normally present without any additional elements, deleted elements or abnormally positioned genetic material. The test determines the karyotype, which is the normal complement of 46 chromosomes (23 from each parent) by arranging them in order of size, centromere location and banding pattern. Chromosomes are composed of DNA and reside within the nucleus of cells. Amniotic fluid chromosome karyotyping is useful in any situation in which there is increased risk of a fetal chromosome abnormality. These conditions include advanced maternal age greater than 35 at delivery, three or more previous spontaneous abortions, fetal abnormality detected by ultrasound which may indicate a chromosomal abnormality, history of a known family genetic abnormality, known carrier of an X-linked disorder and an abnormal prenatal screening test that may indicate a genetic abnormality.
For optimum results, amniotic fluid should be collected between 14 and 18 weeks gestation. Common indications for amniocentesis chromosome analysis include abnormal ultrasound of the fetus, family history of genetic abnormality, prior child with genetic abnormality, abnormal prenatal blood screen and advanced maternal age.

  • Amniotic fluid can be used for tissue culture for chromosome analysis to aid in prenatal diagnosis of chromosome abnormalities which may result in birth defects and congenital abnormalities
  • Prenatal detection of chromosomal abnormalities (eg, Down syndrome)
  • Used as a confirmatory test for abnormal maternal serum screening
  • Screening for chromosomal abnormalities in patients with family history with congenital abnormalities
Chromosomal abnormalities are almost 100% specific for significant chromosome defects; however, very minor abnormalities can usually be detected only by targeted FISH testing. Not all chromosome abnormalities are associated with birth defects. Conversely, a normal compliment of chromosomes does not exclude the possibility of a birth defect. These would include mutations too small to be seen microscopically and point mutations and exposure to teratogenic chemicals. Any deviation from a normal number of chromosomes and a normal banding pattern is considered abnormal. Interpretation depends upon the specific abnormality identified, if any.

Male: 22 pair of autosomal chromosomes (1-22) plus 2 sex chromosomes (X & Y)
Female: 22 pair of autosomal chromosomes (1-22) plus 2 sex chromosomes (X & X)
 

 

Cells in the amniotic fluid are placed in nutrient media and allowed to grow and divide. Cellular division is stopped when the chromosomes are condensed and the chromosomes are spread on a slide and stained to reveal bands within each chromosome. The bands are counted individually in a minimum number of cells to establish any additions, deletions, translocations or other abnormalities.

At least 20 cc of clear amniotic fluid in a sterile centrifuge tube or similar (add 5 cc if ordering FISH analysis).

Place in a sealed biohazard bag. Store and transport at room temperature.

Fluorescence in situ hybridization, Alpha Fetoprotein, Human Chorionic Gonadotropin (HCG), Chromosomal analysis blood, Inhibin A, Pregnancy associated protein A (PAP-A).

1-3 days. 

Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login